Japan’s Ajinomoto has entered into exclusive negotiations with French fermentation firm METabolic EXplorer to sell its entire stake in Ajinomoto Animal Nutrition Europe (AANE), based in Amiens, France. The company said the sale its part of a strategic reshaping of its portfolio and a restructuring of non-core businesses.
Seven companies from the European GET H2 hydrogen initiative, including chemical producer Evonik, have established a consortium to help promote industrial offtake of climate-friendly green hydrogen from renewable energies.
Michael Reubold talked to Evonik’s Sanjeev Taneja about the role of catalysts in the company and their value to the industry and the society.
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Evonik has entered into an agreement to buy the Lactel absorbable polymer business from Durect Corp., a US-based biopharmaceutical company focused on developing drugs for pain and chronic diseases.
German specialty chemicals producer Evonik says it is on track to complete the ongoing €400 million expansion of its PA 12 portfolio as planned, despite a few logistical challenges related to the coronavirus pandemic.
Evonik and Siemens Energy have commissioned a pilot plant that uses carbon dioxide (CO2) and water to produce chemicals. The plant is the culmination of two years’ work under the Rheticus I and II research projects to develop a technically feasible foundation for artificial photosynthesis using a bioreactor and electrolyzers.
The pharmaceutical industry is increasingly focused on the development of specialized drug products with new treatment modalities, including previously undruggable targets for oncology and other areas.
Specialty chemicals producer Evonik is investing around €15 million in its C4 production network in Marl. Germany. The three-pronged focus is on Tert. butanol (TBA), di-isobutene (DiB) and 3,5,5-trimethylhexanal (TMH).
In a move designed to boost its catalyst business, Evonik will pay $210 million to acquire the Porocel Group, a US technology provider based in Houston, Texas. The transaction, to be financed out of Evonik's “strong cash position,” is due to close by the end of 2020 subject to regulatory approval.
The chemical industry is on the threshold of a new era – the age of circularity. We asked industry experts to share their opinions on this transformational topic.
The fate of the agrochemical innovation, development, product launch and production are strongly linked to the parallel development of the fine chemicals and custom manufacturing industry.
